FOLD – amicus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
TD Cowen Cautious on Amicus Therapeutics (FOLD) Despite Positive 2025 Revenue Projections [Yahoo! Finance]
Is Amicus Therapeutics (FOLD) Pricing Reflect Long Term Prospects In Rare Disease Treatments [Yahoo! Finance]
Assessing Amicus Therapeutics (FOLD) Valuation After Strong 3 Month And 1 Year Shareholder Returns [Yahoo! Finance]
Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026
Form 10-K AMICUS THERAPEUTICS, For: Dec 31
Form 8-K AMICUS THERAPEUTICS, For: Feb 20
Form SCHEDULE 13G/A AMICUS THERAPEUTICS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form SCHEDULE 13G/A AMICUS THERAPEUTICS, Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
Form DEFM14A AMICUS THERAPEUTICS,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.